Siddharth Rajkhowa is an associate in the private equity transactions group in London.
Siddharth has a broad range of corporate law experience, including advising private equity investors and their portfolio companies as well as household name corporates and financial institutions. Siddharth has acted on both domestic and cross-border acquisitions, minority investments, disposals, joint ventures and reorganisations, and has substantive experience in heavily regulated sectors such as healthcare, pharmaceuticals & life sciences; retail & consumer goods; technology; financial services; and insurance.
Prior to joining the firm, Siddharth was seconded to UK Government Investments where he assisted on the UK Government's second sale (by way of a securitisation) of income contingent repayment student loans. Siddharth also spent time on secondment to Hong Kong during his training.
Experience
- Advised funds affiliated with BPEA EQT and Tricor on the merger of Vistra and Tricor, creating a $6.5bn global fund and corporate services platform
- Advised funds affiliated with Baring Private Equity Asia on the acquisition of Tricor Group, Asia’s leading business expansion specialist whose corporate mission is to facilitate globalisation in Asia. The transaction valued Tricor at an enterprise value of $2.76 billion
- Advised The Rise Fund, TPG’s multi-sector global impact investing strategy, on the acquisition of a majority interest in Outcomes First Group, a UK-based provider of best-in-class education to young people and adults with autism, learning disabilities, and other complex Special Education Needs
- Advised Partners Group on its investment in GHO Capital Partners’ portfolio company Sterling Pharma Solutions, a global Contract Development and Manufacturing Organization
Notable transactions in which Siddharth has been involved in prior to joining the firm include:
- Advising Alkuri Global Acquisition Corp on its de-SPAC with Babylon Health for a pro forma equity value of approximately $4.2 billion
- Advising Hudson Hill Capital on the management buy-out of the InXpress Group
- Advising Water Street Healthcare Partners on several acquisitions to create the Safeguard Medical platform
- Advising Carval on its co-investment with Intrum on the acquisition from Intesa Sanpaolo of GACS Italian non-performing loans with a gross book value of €10.8 billion
- Advising InvestIndustrial on the sale of Goldcar to Europcar for €550 million
- Advising SABMiller on its €7.3 billion disposal of its Central Eastern European businesses to Asahi